Source link : https://newshealth.biz/health-news/potential-game-changer-for-psoriasis-gets-green-light-from-fda/
The FDA has approved the first oral interleukin (IL)-23-targeted therapy for plaque psoriasis, Johnson & Johnson announced. The approval of icotrokinra (Icotyde) stipulates use in adults and children 12 or older with moderate/severe psoriasis who are candidates for systemic therapy or phototherapy. “Icotyde delivers something unique in psoriasis treatment, combining skin clearance with a favorable […]
The post ‘Potential Game Changer’ for Psoriasis Gets Green Light From FDA first appeared on News Health.
—-
Author : News Health
Publish date : 2026-03-18 16:34:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8